The advent of personalized medicine is a result of countless innovations in an array of fields, including genomic sequencing, big ...

In recent news, Pfizer Chief Executive Officer Ian Read stated he will step down at the end of 2018 after ...

In July, the NIH officially partnered with Google Cloud to launch STRIDES (Science and Technology Research Infrastructure for Discovery, Experimentation, ...

Excellent drug development is critical today, as patients across the world are relying on innovative new treatments and therapies to ...

Pharmaceutical organizations looking to grow into personalized medicine are leveraging high-dollar acquisitions of cell therapy companies to quickly enter the ...

This week, PhRMA, the country’s leading biopharmaceutical research industry group made a bold statement about bringing down the cost of medicines. In ...

Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of RNA interference therapeutics for genetically ...

The shift to personalized medicine, where companies can develop preventive measures and precision treatments to enhance a patient’s unique well-being, ...

Cell therapy, as defined by the American Society of Gene & Cell Therapy, is “the administration of living whole cells ...

The global life sciences industry is on the verge of a revolution that will change how products are developed, marketed, ...

Value-based care models are the future of pharmaceuticals but several obstacles exist slowing the transition from volume selling to value selling. ...

With industry-leading experience designing, configuring, validating, and/or deploying LIMS software solutions for our clients, we’ve had the amazing opportunity to impact ...